Powered by MOMENTUM MEDIA

Website Notifications

Get notifications in real-time for staying up to date with content that matters to you.

Medical Countermeasures Program takes next steps

dmtc mcp round

Three projects have been selected to progress under round two of the Defence Materials Technology Centre’s (DMTC) Medical Countermeasure Program.

Three projects have been selected to progress under round two of the Defence Materials Technology Centre’s (DMTC) Medical Countermeasure Program.

Minister for Defence Industry Christopher Pyne said more than 50 expressions of interest were received from across Australia, and that the three successful projects will share around $5 million worth of funding under the program.

Advertisement
Advertisement

Projects from Flinders Unviersity, in partnership with the Australian Respiratory & Sleep Medicine Institute and Vaxine Pty Ltd; the University of Queensland; and Planet Innovation, with its research partners from CSIRO, were revealed as the successful projects.

"Flinders University, the Australian Respiratory & Sleep Medicine Institute and Adelaide-based SME Vaxine Pty Ltd will work collaboratively to advance the work on vaccines against Japanese encephalitis and related viruses," Minister Pyne said.

"The University of Queensland will lead the development of magnetic nanotechnologies that will assist with the administration of anti-biotics by speeding up the diagnosis of microbial infections.

"Planet Innovation and research partners from CSIRO will partner on a project to further develop a deployable, point of care diagnostic system that can track outbreaks as they happen in real time, minimising the spread of disease."

Minister Pyne said the projects received technical expertise and support from industry and research partners as part of the program.

PROMOTED CONTENT

"That in itself is a great reflection of the dual purpose of the DMTC – to enhance Defence capabilities but also to strengthen the industrial sector supporting Defence," the minister said.

"These projects are a step forward in reducing Australia’s reliance on imported medical countermeasures products.

"Medical countermeasures are an important sovereign capability for military or civilian personnel in a range of scenarios, including biological warfare or chemical attacks, as well as the potential spread of global infectious disease pandemics."

This round of projects has been supported by funding from CSIRO and the Defence Science and Technology Group through its Next Generation Technologies Fund.

The DMTC is a key partner for the Defence Innovation Hub. Launched in 2016, the hub will invest around $640 million over the decade in maturing and further developing technologies that have moved from the early science stages into the engineering and development stages.

Medical Countermeasures Program takes next steps
DMTC-MCP-Round-2.jpg
lawyersweekly logo

The inaugural Defence Connect AIC Summit will place you with key decision-makers and stakeholders within the defence industry to discuss the government’s intention to improve AIC and increase the nation’s sovereign production, defence capability and resilience. Don’t miss your chance to be part of this event, register for free today to attend the live stream on 22 October. Register your interest to attend, visit: www.defenceconnect.com.au/aic-summit

more from defence connect

NSW firm tapped to build Army vehicle fleet
Sep 24 2021
NSW firm tapped to build Army vehicle fleet
A multimillion-dollar contract has been awarded to a Port Macquarie-based business for the develop of rough terrain vehicles. ...
Sep 24 2021
QUT to develop technology to identify fallen Australian soldiers
The Morrison government has granted the Queensland University of Technology with a $2.2 million contract to develop forensic techn...
Sep 24 2021
MH-60R Seahawk achieves operational milestone
The Royal Australian Navy helicopter has surpassed 2,000 flight hours while on deployment in south-east Asia. ...